Simplify Asset Management Inc. Gilead Sciences, Inc. Transaction History

Simplify Asset Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $89,682 - $101,702	-1,224 Reduced 6.81%	16,750 $1.36 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $500,130 - $545,651	6,764 Added 60.34%	17,974 $1.35 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $210,699 - $240,332	2,772 Added 32.85%	11,210 $863,000
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $322,846 - $367,822	4,176 Added 97.98%	8,438 $700,000
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $21,375 - $30,688	343 Added 8.75%	4,262 $365,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $233,337 - $266,531	3,919 New	3,919 $242,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Simplify Asset Management Inc. with notifications on news.